Chargement en cours...

MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat

The primary limitation of thrombolytic treatment of ischemic stroke with tPA is the hemorrhagic risk. We tested AcSDKP (N-acetyl-seryl-aspartyl-lysyl-proline), as an auxiliary therapeutic agent, to reduce blood-brain barrier (BBB) disruption in a combination tPA thrombolytic treatment of stroke. Wis...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ding, Guangliang, Zhang, Zhenggang, Chopp, Michael, Li, Lian, Zhang, Li, Li, Qingjiang, Wei, Min, Jiang, Quan
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4044825/
https://ncbi.nlm.nih.gov/pubmed/24769225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroscience.2014.04.025
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!